A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Keith M. Channon, Azfar Zaman et al.|International Journal of Cardiology|2021Cited by 16
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 TrialDirk von Lewinski, Markus Wallner, Martin Benedikt et al.|Journal of Clinical Medicine|2022Cited by 3
A Randomised, Double-Blind, Dose Ranging Clinical Trial of Intravenous FDY-5301 in Acute STEMI Patients Undergoing Primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) StudyDavid Adlam, CCC-ACS Investigators, N. Uren et al.|Circulation|2019Cited by 1